Effect of SCCA1 and SCCA2 on the suppression of TNF-α-induced cell death by impeding the release of mitochondrial cytochrome c in an oral squamous cell carcinoma cell line

Tumor Biology

Volumn 26, Issue 4, 2005, Pages 165-172

  Hashimoto, Ken Ichiro ^a,b   Kiyoshima, Tamotsu ^b   Matsuo, Kou ^b   Ozeki, Satoru ^a   Sakai, Hidetaka ^b,c  

^a FUKUOKA DENTAL COLLEGE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Caspase; Cytochrome c; Oral cancer; SCCA; Squamous cell carcinoma; TNF

Indexed keywords

CASPASE 9; COMPLEMENTARY DNA; CYTOCHROME C; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; CASP9 PROTEIN, HUMAN; CASPASE; MESSENGER RNA; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA RELATED ANTIGEN; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TUMOR ANTIGEN;

ARTICLE; CELL DEATH; CELL LINE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MITOCHONDRION; MOUTH CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; STAINING; APOPTOSIS; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUTH TUMOR; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANTIGENS, NEOPLASM; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASPASE 9; CASPASES; CELL LINE, TUMOR; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MITOCHONDRIA; MOUTH NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERPINS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 24644445166     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086949     Document Type: Article

References (28)

1. Kato H, Torigoe T: Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977;40:1621-1628.
2. Brioshi PA, Bischof P, Delafosse C, Krauer F: Squamous-cell carcinoma antigen (SCC-A) values related to clinical outcome of pre-invasive and invasive cervical carcinoma. Int J Cancer 1991;47:376-379.
3. Suminami Y, Kishi F, Sekiguchi K, Kato H: Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem Biophys Res Commun 1991;181:551-558.
4. Miura M, Friedlander RM, Yuan J: Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc Natl Acad Sci USA 1995;92:8318-8322.
5. Dickinson JL, Norris BJ, Jensen PH. Antalis TM: The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-α induced apoptosis. Cell Death Differ 1998;5:163-171.
6. Sun J, Bird CH, Sutton V, McDonald L, Coughlin PB, De Jong TA, Trapani JA, Bird PI: A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J Biol Chem 1996;271:27802-27809.
7. Schneider SS, Schick C, Fish KE, Miller E, Pena JC, Treter SD, Hui SM, Silverman GA: A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci USA 1995;92:3147-3151.
8. Schick C, Pemberton PA, Shi GP, Kamachi Y, Cataltepe S, Bartuski AJ, Gornstein ER, Brömme D, Chapman HA, Silverman GA: Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: A kinetic analysis. Biochemistry 1998;37:5258-5266.
9. Schick C, Kamachi Y, Bartuski AJ, Cataltepe S, Schechter NM, Pemberton PA, Silverman GA: Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase. J Biol Chem 1997;272:1849-1855.
10. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP: Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999;17:331-367.
11. Heller RA, Krönke M: Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 1994;126:5-9.
12. Dbaibo GS, Perry DK, Gamard CJ, Platt R, Poirier GG, Obeid LM, Hannun YA: Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-α: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J Exp Med 1997;185:481-490.
13. Monney L, Olivier R, Otter I, Jansen B, Poirier GG, Borner C: Role of an acidic compartment in tumor-necrosis-factor-α-induced production of ceramide, activation of caspase-3 and apoptosis. Eur J Biochem 1998;251:295-303.
14. Zhou Q, Salvesen GS: Activation of pro-caspase-7 by serine proteases includes a non-canonical specificity. Biochem J 1997;324:361-364.
15. Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, Kaufmann SH, Gores GJ: Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 2000;106:1127-1137.
16. Hengartner MO: The biochemistry of apoptosis. Nature 2000;407:770-776.
17. Adrain C, Martin SJ: The mitochondrial apoptosome: A killer unleashed by the cytochrome seas. Trends Biochem Sci 2001;26:390-397.
18. Heinrich M, Neumeyer J, Jakob M, Hallas C, Tchikov V, Winoto-Morbach S, Wickel M, Schneider-Brachert W, Trauzold A, Hethke A, Schutze S: Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ 2004;11:550-563.
19. Suminami Y, Nagashima S, Vujanovic NL, Hirabayashi K, Kato H, Whiteside TL: Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1. Br J Cancer 2000;82:981-989.
20. McGettrick AF, Barnes RC, Worrall DM: SCCA2 inhibits TNF-mediated apoptosis in transfected HeLa cells. The reactive centre loop sequence is essential for this function and TNF-induced cathepsin G is a candidate target. Eur J Biochem 2001;268:5868-5978.
21. Matsuo K, Ishibashi Y, Kobayashi I, Ozeki S, Ohishi M, Tange T, Hirata J, Kiyoshima T, Sakai H: New human oral squamous carcinoma cell line and its tumorigenic subline producing granulocyte colony-stimulating factor. Jpn J Cancer Res 1994;85:1257-1262.
22. Murakami A, Suminami Y, Hirakawa H, Nawata S, Numa F, Kato H: Squamous cell carcinoma antigen suppresses radiation-induced cell death. Br J Cancer 2001;84:851-858.
23. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998;94:481-490.
24. Yin XM, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B, Roth KA, Korsmeyer SJ: Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 1999;400:886-891.
25. Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, Boes M, Elling F, Leist M, Jäättelä M: Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 2001;153:999-1009.
26. Stoka V, Turk B, Schendel SL, Kim TH, Cirman T, Snipas SJ, Ellerby LM, Bredesen D, Freeze H, Abrahamson M, Brömme D, Krajewski S, Reed JC, Yin XM, Turk V, Salvesen GS: Lysosomal protease pathways to apoptosis: Cleave of Bid, not pro-caspase, is the most likely route. J Biol Chem 2001;276:3149-3157.
27. Cirman T, Orešić K, Mazovec GD, Turk V, Reed JC, Myers RM, Salvesen GS, Turk B: Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 2004;279:3578-3587.
28. Hatai T, Matsuzawa A, Inoshita S, Mochida Y, Kuroda T, Sakamaki K, Kuida K, Yonehara S, Ichijo H, Takeda K: Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activation. J Biol Chem 2000;275:26576-26581.